Abiopharma

🔍 Manuel Anja (Director)

Company: Hims & Hers Health, Inc. (HIMS)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Acquired 8,223 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,223.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award.